The inclusion of flagellin in nanoparticles as a part of the fusion protein NA-FliC/M2e [183] or co-administration of NP-NA nanoparticles with monophosphoryl lipid A (MPLA, a toll-like receptor 4 agonist) has been shown to enhance immune response and provide improved protection against influenza [184]. Here, XK is linked to influenza.